AAAAAA

   
Results: 1-24 |
Results: 24
Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's - Associated adenocarcinoma
Authors: Brabender, J Lord, RV Danenberg, KD Metzger, R Schneider, PM Uetake, H Kawakami, K Park, JM Salonga, D Peters, JH DeMeester, TR Holscher, AH Danenberg, PV
Citation: J. Brabender et al., Upregulation of ornithine decarboxylase mRNA expression in Barrett's esophagus and Barrett's - Associated adenocarcinoma, J GASTRO S, 5(2), 2001, pp. 174-181
Epidermal growth factor receptor and HER2-neu mRNA expression in non-smallcell lung cancer is correlated with survival
Authors: Brabender, J Danenberg, KD Metzger, R Schneider, PM Park, JM Salonga, D Holscher, AH Danenberg, PV
Citation: J. Brabender et al., Epidermal growth factor receptor and HER2-neu mRNA expression in non-smallcell lung cancer is correlated with survival, CLIN CANC R, 7(7), 2001, pp. 1850-1855
Superconducting tapes using ISD buffer layers produced by evaporation of MgO or reactive evaporation of magnesium
Authors: Metzger, R Bauer, M Numssen, K Semerad, R Berberich, P Kinder, H
Citation: R. Metzger et al., Superconducting tapes using ISD buffer layers produced by evaporation of MgO or reactive evaporation of magnesium, IEEE APPL S, 11(1), 2001, pp. 2826-2829
Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival
Authors: Brabender, J Usadel, H Danenberg, KD Metzger, R Schneider, PM Lord, RV Wickramasinghe, K Lum, CE Park, J Salonga, D Singer, J Sidransky, D Holscher, AH Meltzer, SJ Danenberg, PV
Citation: J. Brabender et al., Adenomatous polyposis coli gene promoter hypermethylation in non-small cell lung cancer is associated with survival, ONCOGENE, 20(27), 2001, pp. 3528-3532
Towards in-vitro prediction of an in-vivo cytostatic response of human tumor cells with a fast chemosensitivity assay
Authors: Metzger, R Deglmann, CJ Hoerrlein, S Zapf, S Hilfrich, J
Citation: R. Metzger et al., Towards in-vitro prediction of an in-vivo cytostatic response of human tumor cells with a fast chemosensitivity assay, TOXICOLOGY, 166(1-2), 2001, pp. 97-108
Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: Results at 2 years
Authors: Ahsan, N Johnson, C Gonwa, T Halloran, P Stegall, M Hardy, M Metzger, R Shield, C Rocher, L Scandling, J Sorensen, J Mulloy, L Light, J Corwin, C Danovitch, G Wachs, M VanVeldhuisen, P Salm, K Tolzman, D Fitzsimmons, WE
Citation: N. Ahsan et al., Randomized trial of tacrolimus plus mycophenolate mofetil or azathioprine versus cyclosporine oral solution (modified) plus mycophenolate mofetil after cadaveric kidney transplantation: Results at 2 years, TRANSPLANT, 72(2), 2001, pp. 245-250
Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma
Authors: Brabender, J Lord, RV Danenberg, KD Metzger, R Schneider, PM Park, JM Salonga, D Groshen, S Tsao-Wei, DD DeMeester, TR Holscher, AH Danenberg, PV
Citation: J. Brabender et al., Increased c-myb mRNA expression in Barrett's esophagus and Barrett's-associated adenocarcinoma, J SURG RES, 99(2), 2001, pp. 301-306
Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer
Authors: Muller-Tidow, C Metzger, R Kugler, K Diederichs, S Idos, G Thomas, M Dockhorn-Dworniczak, B Schneider, PM Koeffler, HP Berdel, WE Serve, H
Citation: C. Muller-tidow et al., Cyclin E is the only cyclin-dependent kinase 2-associated cyclin that predicts metastasis and survival in early stage non-small cell lung cancer, CANCER RES, 61(2), 2001, pp. 647-653
Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer
Authors: Muller-Tidow, C Kugler, K Diederichs, S Klumpen, S Moller, M Vogt, U Metzger, R Schneider, PM Berdel, WE Serve, H
Citation: C. Muller-tidow et al., Loss of expression of HDAC-recruiting methyl-CpG-binding domain proteins in human cancer, BR J CANC, 85(8), 2001, pp. 1168-1174
Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase
Authors: Salonga, D Danenberg, KD Johnson, M Metzger, R Groshen, S Tsao-Wei, DD Lenz, HJ Leichman, CG Leichman, L Diasio, RB Danenberg, PV
Citation: D. Salonga et al., Colorectal tumors responding to 5-fluorouracil have low gene expression levels of dihydropyrimidine dehydrogenase, thymidylate synthase, and thymidine phosphorylase, CLIN CANC R, 6(4), 2000, pp. 1322-1327
In vitro toxicology in hepatocyte bioreactors-extracellular acidification rate (EAR) in a target cell line indicates hepato-activated transformation of substrates
Authors: Koebe, HG Deglmann, CJ Metzger, R Hoerrlein, S Schildberg, FW
Citation: Hg. Koebe et al., In vitro toxicology in hepatocyte bioreactors-extracellular acidification rate (EAR) in a target cell line indicates hepato-activated transformation of substrates, TOXICOLOGY, 154(1-3), 2000, pp. 31-44
Organ-specific distribution of major histocompatibility antigens in rats
Authors: Metzger, R Mempel, T Joppich, I Till, H
Citation: R. Metzger et al., Organ-specific distribution of major histocompatibility antigens in rats, PEDIAT SURG, 16(4), 2000, pp. 285-292
Proliferation, zonal maturation, and steroid production of fetal adrenal transplants in adrenalectomized rats
Authors: Till, H Metzger, R Mempel, T Boehm, R Joppich, I
Citation: H. Till et al., Proliferation, zonal maturation, and steroid production of fetal adrenal transplants in adrenalectomized rats, PEDIAT SURG, 16(4), 2000, pp. 293-296
Somatic isoform of angiotensin I-converting enzyme in the pathology of testicular germ cell tumors
Authors: Franke, FE Pauls, K Kerkman, L Steger, K Klonisch, T Metzger, R Alhenc-Gelas, F Burkhardt, E Bergmann, M Danilov, SM
Citation: Fe. Franke et al., Somatic isoform of angiotensin I-converting enzyme in the pathology of testicular germ cell tumors, HUMAN PATH, 31(12), 2000, pp. 1466-1476
Preoperative radiochemotherapy of esophageal cancer. Light at the end of the tunnel?
Authors: Holscher, AH Metzger, R Schneider, PM
Citation: Ah. Holscher et al., Preoperative radiochemotherapy of esophageal cancer. Light at the end of the tunnel?, ZBL CHIR, 125(4), 2000, pp. 319-325
Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation
Authors: Johnson, C Ahsan, N Gonwa, T Halloran, P Stegall, M Hardy, M Metzger, R Shield, C Rocher, L Scandling, J Sorensen, J Mulloy, L Light, J Corwin, C Danovitch, G Wachs, M VanVeldhuisen, P Salm, K Tolzman, D Fitzsimmons, WE
Citation: C. Johnson et al., Randomized trial of tacrolimus (Prograf) in combination with azathioprine or mychophenolate mofetil versus cyclosporine (Neoral) with mycophenolate mofetil after cadaveric kidney transplantation, TRANSPLANT, 69(5), 2000, pp. 834-841
Adsorption of precursor molecules in the CVD process of (Ba;Sr)titanate simulated by ab-initio calculations
Authors: Metzger, R Werner, C Spitzer, A
Citation: R. Metzger et al., Adsorption of precursor molecules in the CVD process of (Ba;Sr)titanate simulated by ab-initio calculations, THIN SOL FI, 365(2), 2000, pp. 242-250
Dystopic urethral orifice into the anus in the absence of the penile urethra and right kidney
Authors: Metzger, R Stehr, M Schuster, T Dietz, HG Joppich, I
Citation: R. Metzger et al., Dystopic urethral orifice into the anus in the absence of the penile urethra and right kidney, J UROL, 164(2), 2000, pp. 487-488
CD143 in the development of atherosclerosis
Authors: Metzger, R Bohle, RM Chumachenko, P Danilov, SM Franke, FE
Citation: R. Metzger et al., CD143 in the development of atherosclerosis, ATHEROSCLER, 150(1), 2000, pp. 21-31
Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non small cell lung cancer
Authors: Schneider, PM Praeuer, HW Stoeltzing, O Boehm, J Manning, J Metzger, R Fink, U Wegerer, S Hoelscher, AH Roth, JA
Citation: Pm. Schneider et al., Multiple molecular marker testing (p53, C-Ki-ras, c-erbB-2) improves estimation of prognosis in potentially curative resected non small cell lung cancer, BR J CANC, 83(4), 2000, pp. 473-479
Histomorphologic regression grading and apoptotic-index as objective response parameters for adenocarcinomas of the stomach and esophagogastric junction treated with neoadjuvant chemotherapy
Authors: Schneider, PM Zirbes, TK Metzger, R Baldus, S Dienes, HP Holscher, AH
Citation: Pm. Schneider et al., Histomorphologic regression grading and apoptotic-index as objective response parameters for adenocarcinomas of the stomach and esophagogastric junction treated with neoadjuvant chemotherapy, LANG ARCH S, 1999, pp. 109-115
Lack of specificity of [S-35]-ATP gamma S and [S-35]-ADP beta S as radioligands for ionotropic and metabotropic P2 receptor binding
Authors: Yu, HX Bianchi, B Metzger, R Lynch, KJ Kowaluk, EA Jawis, MF van Biesen, T
Citation: Hx. Yu et al., Lack of specificity of [S-35]-ATP gamma S and [S-35]-ADP beta S as radioligands for ionotropic and metabotropic P2 receptor binding, DRUG DEV R, 48(2), 1999, pp. 84-93
Angiotensin-converting enzyme in non-neoplastic kidney diseases
Authors: Metzger, R Bohle, RM Pauls, K Eichner, G Alhenc-Gelas, F Danilov, SM Franke, FE
Citation: R. Metzger et al., Angiotensin-converting enzyme in non-neoplastic kidney diseases, KIDNEY INT, 56(4), 1999, pp. 1442-1454
Pharmacological characterization of recombinant human and rat P2X receptorsubtypes
Authors: Bianchi, BR Lynch, KJ Touma, E Niforatos, W Burgard, EC Alexander, KM Park, HS Yu, HX Metzger, R Kowaluk, E Jarvis, MF van Biesen, T
Citation: Br. Bianchi et al., Pharmacological characterization of recombinant human and rat P2X receptorsubtypes, EUR J PHARM, 376(1-2), 1999, pp. 127-138
Risultati: 1-24 |